WASATCH ADVISORS LP

Position in AQST — Aquestive Therapeutics, Inc.

CIK 814133 SALT LAKE CITY, UT

Position in AQST

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$5,765,106

+$2,120,095 QoQ

Shares Held

1,385,843

+57.8% QoQ

Ownership

1.10%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#12

of 185 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WASATCH ADVISORS LP holds $35,462,974 across 4 Drug Manufacturers - Specialty & Generic names. AQST ranks #3 (16.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DERM	Journey Medical Corp	2,858,930	$20,241,224
2			1,930,185	$6,099,384
3	AQST	Aquestive Therapeutics, Inc. This page	1,385,843	$5,765,106
4	ETON	Eton Pharmaceuticals, Inc.	92,742	$3,357,260

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,765,106	1,385,843	+57.8%	Shares	Sole	2026-07-10
2026-03-31	$3,645,011	878,316	+28.9%	Shares	Sole	2026-04-21
2025-12-31	$4,400,810	681,240	-5.9%	Shares	Sole	2026-02-12
2025-09-30	$4,048,714	724,278	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.